Pharmacologic Management of Dyslipidemia in Primary Care
-
Register
- User - $45
This presentation analyzes the most current guidelines for the management of dyslipidemia for both a primary prevention and for risk reduction in the patient who has already had a coronary artery event. Evaluation of the mechanisms of action of the newest lipid-lowering agents is presented in setting of clinical relevant case studies to provide
Credits: 1.50 Contact Hours; 1.50 are Pharmacology
Expiration Date: December 31, 2025
$45
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Analyze newest guideline recommendations for the treatment of dyslipidemia
-Compare and contrast pharmacotherapeutic options for the very high-risk patient
-Apply treatment guidelines to both average and very high-risk patient
Sally K. Miller, PhD, APRN, FAANP, PMHNP-BC, FNP-BC, AGACNP-BC, AGPCNP-BC
Clinical Professor, Drexel University CNHP
Nurse Practitioner, iCarePsychiatry and Sahara Family Practice
Dr. Sally Miller has been practicing as a nurse practitioner for 30 years. She is board certified as a family NP, Adult/Geriatric Acute and Primary NP, and Psych/Mental Health NP. Dr. Miller is a clinical professor with Drexel University College of Nursing and Health Professions. She maintains an active clinical practice with Sahara Family Practice and Theravada Wellness. Sally has published over 30 research and clinical articles with emphasis on issues related to adult health and illness as well as obesity. She has been an active conference presenter and author in the NP community since 1996.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Sally Miller, PhD, APRN, FNP-BC, AGACNP-BC, AGPCNP-BC, FAANP has disclosed no financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
